The impact of COVID-19 pandemic on vascular registries and clinical trials.
Faisal Aziz, Christian-Alexander Behrendt, Kaity Sullivan, Adam W Beck, C Barry Beiles, Jon R Boyle, Kevin Mani, Ruth A Benson, Max V Wohlauer, Manar Khashram, Jens Eldrup Jorgensen, Gary W Lemmon
Semin Vasc Surg | Published : 2021
Quality improvement programs and clinical trial research experienced disruption due to the coronavirus disease 2019 (COVID-19) pandemic. Vascular registries showed an immediate impact with significant declines in second-quarter vascular procedure volumes witnessed across Europe and the United States. To better understand the magnitude and impact of the pandemic, organizations and study groups sent grass roots surveys to vascular specialists for needs assessment. Several vascular registries responded quickly by insertion of COVID-19 variables into their data collection forms. More than 80% of clinical trials have been reported delayed or not started due to factors that included loss of enroll..View full abstract